Economic Burden of Cancer in Korea during 2000-2010
Economic Burden of Cancer in Korea during 2000-2010
复制标题
DOI：
10.4143/crt.2014.001
复制
发表时间：
2015-07-01
影响因子：
4.6
通讯作者：
Park, Eun-Cheol
中科院分区：
文献类型：
--
作者：
Lee, Kwang-Sig;Chang, Hoo-Sun;Park, Eun-Cheol
PurposeThis study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site，gender，age group，and cost components.Materials and MethodsData from national health insurance claims data and information from Statistics Korea.基于疾病的成本方法，本研究计算了直接，发病率和死亡率的癌症在全国范围内的成本在2000-2010年的癌症部位，性别，和年龄组。结果与平均年增长率为8.9%，癌症在韩国的经济负担从11,424万美元（现价美元）在2000-2010年期间增加到20,858万美元（现价美元）。结直肠癌、甲状腺癌和乳腺癌在此期间变得更加重要，即，2000年的第5/837、第11/257和第7/529分别上升到2010年的第3/2，210、第5/1，724和第6/1，659（排名/总人口百万美元）。此外，就同一指标而言，肝癌和胃癌在这一期间也很突出，即，从2000年的1/2，065和2/2，036分别上升到2010年的1/3，114和2/3，046。最后，在2000-2010年期间，韩国的死亡成本在总负担中的份额从71%下降到51%，在此期间，结直肠癌，甲状腺癌，乳腺癌和前列腺癌占主导地位。这些结果表明，在韩国的癌症的经济负担的特点是越来越重要的慢性component.ConclusionIncorporation独特的流行病学，社会文化背景到韩国的癌症控制计划，更加重视初级预防，如钠控制饮食和B型肝炎疫苗接种，可能是必要的。
PurposeThis study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component.Materials and MethodsData came from national health insurance claims data and information from Statistics Korea. Based on the cost of illness method, this study calculated direct, morbidity and mortality cost of cancer in the nation during 2000-2010 by cancer site, gender, and age group.ResultsWith an average annual growth rate of 8.9%, the economic burden of cancer in Korea increased from 11,424 to 20,858 million US$ (current US dollars) during 2000-2010. Colorectal, thyroid, and breast cancers became more significant during the period, i.e., the 5th/837, the 11th/257, and the 7th/529 in 2000 to the 3rd/2,210, the 5th/1,724, and the 6th/1,659 in 2010, respectively (rank/amount in million US$ for the total population). In addition, liver and stomach cancers were prominent during the period in terms of the same measures, i.e., the 1st/2,065 and the 2nd/2,036 in 2000 to the 1st/3,114 and the 2nd/3,046 in 2010, respectively. Finally, the share of mortality cost in the total burden dropped from 71% to 51% in Korea during 2000-2010, led by colorectal, thyroid, breast, and prostate cancers during the period. These results show that the economic burden of cancer in Korea is characterized by an increasing importance of chronic components.ConclusionIncorporation of distinctive epidemiological, sociocultural contexts into Korea's cancer control program, with greater emphasis on primary prevention such as sodium-controlled diet and hepatitis B vaccination, may be needed.